Showing results (81-90 of 369) with videos related to

Sort By:
Pageof 37
Medicinal Chemistry (Shariqah (United Arab Emirates))|March 6, 2012
Synthesis and preliminary antihyperlipidaemic activities evaluation of andrographolide derivativesBin Wang, Chunlei Tang, Yaodan Han, et al.
Acta Neurochirurgica|February 10, 2017
Bilateral cavernous carotid aneurysms treated by two-stage extracranial-intracranial bypass followed by parent artery occlusion: case report and literature reviewYaoling Liu, Xiang'en Shi, Fangjun Liu, et al.
Organic Letters|May 1, 2013
Cyanide detection using a triazolopyridinium saltThomas F Robbins, Hai Qian, Xin Su, et al.
European Journal of Medicinal Chemistry|September 25, 2018
Exploration of novel pyrrolo[2,1-f][1,2,4]triazine derivatives with improved anticancer efficacy as dual inhibitors of c-Met/VEGFR-2Wei Shi, Hao Qiang, Dandan Huang, et al.
European Journal of Medicinal Chemistry|January 4, 2014
Design, synthesis and biological evaluation of novel peptide MC62 analogues as potential antihyperglycemic agentsBaowei Yang, Yicheng Mei, Xuekun Wang, et al.
Expert Opinion on Therapeutic Patents|November 10, 2023
An updated patent review of GPR40/ FFAR1 modulators (2020 - present)Qiang Ren, Yiqing Fan, Lixin Yang, et al.
Bioorganic & Medicinal Chemistry|January 23, 2016
Design, synthesis and biological evaluation of novel analgesic agents targeting both cyclooxygenase and TRPV1Lin Yan, Miaobo Pan, Mian Fu, et al.
Chemical Biology & Drug Design|September 12, 2015
Synthesis of Analogues of BCTC Incorporating a Pyrrolidinyl Linker and Biological Evaluation as Transient Receptor Potential Vanilloid 1 AntagonistsLin Yan, Jingjie Wang, Miaobo Pan, et al.
Zhongguo Ying Yong Sheng Li Xue Za Zhi = Zhongguo Yingyong Shenglixue Zazhi = Chinese Journal of Applied Physiology|November 2, 2013
[Protective effect of oxiracetam on traumatic brain injury in rats]Jian-Wei Li, Dong-Jun Yang, Xu-Yi Chen, et al.
Expert Opinion on Investigational Drugs|May 13, 2016
Free fatty acid receptor agonists for the treatment of type 2 diabetes: drugs in preclinical to phase II clinical developmentZheng Li, Qianqian Qiu, Xinqian Geng, et al.
Pageof 37